公司资料
Catheter Precision 股价、新闻与催化剂
- 股票代码:
- VTAK
- 交易所:
- NYSE
- 行业:
- MedTech
- 所在地:
- United States
股票表现
0.23 USD (-18.57%)
收盘价
最后更新: 2026年8月17日
2.58M USD
市值
股价为何变动
The latest monitored company update is “Flyte Partners with FullPAC to Bring Regional Aviation to the $11.4 Billion U.S. Political Campaign Market.” The corresponding closing-price reaction is not yet available.
公司概览
业务概览
Catheter Precision is a medical technology company focused on electrophysiology and catheter-based tools used in cardiac procedures. Its business is centered on procedural guidance rather than drug development.
所在地与行业分类
Catheter Precision is headquartered in the United States and listed on NASDAQ. It sits in cardiac-device medtech rather than biotechnology.
商业模式特征
The company depends on device adoption, physician training, and regulatory or commercial milestones in electrophysiology labs. Investors watch product uptake, procedure placement, and operating execution.
生物医药行业定位
Catheter Precision occupies a cardiac-device niche within healthcare innovation. It is not biotech, but it belongs in the procedural-medtech layer where clinical adoption drives value.
未来催化剂
- Catheter Precision’s catalysts are EP-device adoption, procedural workflow growth, and any strategic update that clarifies the company’s commercialization path. The market will care about whether the platform can keep winning procedure share.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。